This session will begin with a conversation with US Representative, California, Anna Eshoo followed by a panel discussion.

During the pandemic, the increased use of virtual care has been an important tool to ensure that patients stay in communication with their health-care providers. However, with fewer in-person visits, the impact of COVID-19 on people living with chronic diseases may be greater than we realize. Efforts to flatten the curve have resulted in deferring care for non-COVID patients. This is raising concerns that medical conditions that might normally have been caught will go undetected, adding to the psychosocial and economic cost for patients, the health-care system, and society. How can we build on the remarkable innovations developed in response to the pandemic to address the chronic non-COVID conditions that millions of people continue to live with? Should we expect an influx of patients seeking screenings, diagnoses, and treatments once the pandemic recedes? Have we effectively addressed the needs of patients outside of COVID-19?

Part 1:

• Guest Anna Eshoo, US Representative, California; Chair, Energy and Commerce Subcommittee on Health, US House of Representatives
• Moderator Esther Krofah, Executive Director, FasterCures, Milken Institute

Part 2:

• Moderator Lynn Goldman, Michael and Lori Milken Dean of Public Health, Milken Institute School of Public Health, The George Washington University
• Speaker Mike Gladstone, Global President, Inflammation and Immunology, Pfizer
• Speaker Caren Heller, Chief Scientific Officer, Crohn's & Colitis Foundation of America
• Speaker Shantanu Nundy, Chief Medical Officer, Accolade; Primary Care Physician; Author, "Care After Covid: What the Pandemic Revealed is Broken in Healthcare and How to Reinvent It"
• Speaker Gary Puckrein, President and CEO, National Minority Quality Forum